nodes	percent_of_prediction	percent_of_DWPC	metapath
Fondaparinux sodium—SERPINC1—Glypican 1 network—BLK—systemic scleroderma	0.00883	0.257	CbGpPWpGaD
Fondaparinux sodium—F10—Beta2 integrin cell surface interactions—TGFBI—systemic scleroderma	0.00682	0.198	CbGpPWpGaD
Fondaparinux sodium—F10—Beta2 integrin cell surface interactions—ITGAM—systemic scleroderma	0.00494	0.144	CbGpPWpGaD
Fondaparinux sodium—F10—Beta2 integrin cell surface interactions—CD40LG—systemic scleroderma	0.00291	0.0847	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Glypican 1 network—TGFB1—systemic scleroderma	0.00229	0.0667	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—SELP—systemic scleroderma	0.00111	0.0323	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—RHOB—systemic scleroderma	0.00104	0.0302	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—CSK—systemic scleroderma	0.000944	0.0275	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—ITGAM—systemic scleroderma	0.000888	0.0258	CbGpPWpGaD
Fondaparinux sodium—Decreased appetite—Leflunomide—systemic scleroderma	0.000823	0.000852	CcSEcCtD
Fondaparinux sodium—Confusional state—Lisinopril—systemic scleroderma	0.00082	0.00085	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.00082	0.000849	CcSEcCtD
Fondaparinux sodium—Headache—Mometasone—systemic scleroderma	0.000819	0.000849	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000817	0.000846	CcSEcCtD
Fondaparinux sodium—Insomnia—Mycophenolic acid—systemic scleroderma	0.000817	0.000846	CcSEcCtD
Fondaparinux sodium—Fatigue—Leflunomide—systemic scleroderma	0.000816	0.000845	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000814	0.000843	CcSEcCtD
Fondaparinux sodium—Oedema—Lisinopril—systemic scleroderma	0.000814	0.000843	CcSEcCtD
Fondaparinux sodium—Pruritus—Captopril—systemic scleroderma	0.000813	0.000842	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000811	0.00084	CcSEcCtD
Fondaparinux sodium—Pain—Leflunomide—systemic scleroderma	0.00081	0.000838	CcSEcCtD
Fondaparinux sodium—Constipation—Leflunomide—systemic scleroderma	0.00081	0.000838	CcSEcCtD
Fondaparinux sodium—Infection—Lisinopril—systemic scleroderma	0.000808	0.000837	CcSEcCtD
Fondaparinux sodium—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000807	0.000836	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000805	0.000834	CcSEcCtD
Fondaparinux sodium—Somnolence—Mycophenolic acid—systemic scleroderma	0.000803	0.000832	CcSEcCtD
Fondaparinux sodium—Shock—Lisinopril—systemic scleroderma	0.0008	0.000829	CcSEcCtD
Fondaparinux sodium—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000798	0.000826	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000797	0.000825	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000795	0.000823	CcSEcCtD
Fondaparinux sodium—Tachycardia—Lisinopril—systemic scleroderma	0.000794	0.000822	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Azathioprine—systemic scleroderma	0.000793	0.000821	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Azathioprine—systemic scleroderma	0.000793	0.000821	CcSEcCtD
Fondaparinux sodium—Skin disorder—Lisinopril—systemic scleroderma	0.00079	0.000818	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000786	0.000814	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Captopril—systemic scleroderma	0.000786	0.000814	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000785	0.000813	CcSEcCtD
Fondaparinux sodium—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000785	0.000813	CcSEcCtD
Fondaparinux sodium—Irritability—Methotrexate—systemic scleroderma	0.000784	0.000812	CcSEcCtD
Fondaparinux sodium—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000783	0.000811	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Leflunomide—systemic scleroderma	0.00078	0.000808	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.00078	0.000808	CcSEcCtD
Fondaparinux sodium—Fatigue—Mycophenolic acid—systemic scleroderma	0.000779	0.000806	CcSEcCtD
Fondaparinux sodium—Nausea—Mometasone—systemic scleroderma	0.000777	0.000805	CcSEcCtD
Fondaparinux sodium—Anorexia—Lisinopril—systemic scleroderma	0.000775	0.000803	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000774	0.000802	CcSEcCtD
Fondaparinux sodium—Pain—Mycophenolic acid—systemic scleroderma	0.000772	0.0008	CcSEcCtD
Fondaparinux sodium—Constipation—Mycophenolic acid—systemic scleroderma	0.000772	0.0008	CcSEcCtD
Fondaparinux sodium—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000772	0.000799	CcSEcCtD
Fondaparinux sodium—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000768	0.000795	CcSEcCtD
Fondaparinux sodium—Cough—Mycophenolate mofetil—systemic scleroderma	0.000762	0.000789	CcSEcCtD
Fondaparinux sodium—Hypotension—Lisinopril—systemic scleroderma	0.00076	0.000787	CcSEcCtD
Fondaparinux sodium—Dizziness—Captopril—systemic scleroderma	0.00076	0.000787	CcSEcCtD
Fondaparinux sodium—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000757	0.000784	CcSEcCtD
Fondaparinux sodium—Urticaria—Leflunomide—systemic scleroderma	0.000752	0.000779	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Leflunomide—systemic scleroderma	0.000748	0.000775	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Leflunomide—systemic scleroderma	0.000748	0.000775	CcSEcCtD
Fondaparinux sodium—Acute coronary syndrome—Prednisone—systemic scleroderma	0.000747	0.000773	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000744	0.000771	CcSEcCtD
Fondaparinux sodium—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000744	0.00077	CcSEcCtD
Fondaparinux sodium—Myocardial infarction—Prednisone—systemic scleroderma	0.000743	0.000769	CcSEcCtD
Fondaparinux sodium—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000741	0.000767	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Azathioprine—systemic scleroderma	0.000739	0.000765	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000739	0.000765	CcSEcCtD
Fondaparinux sodium—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000738	0.000765	CcSEcCtD
Fondaparinux sodium—Insomnia—Lisinopril—systemic scleroderma	0.000736	0.000762	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Lisinopril—systemic scleroderma	0.000731	0.000757	CcSEcCtD
Fondaparinux sodium—Vomiting—Captopril—systemic scleroderma	0.00073	0.000756	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Lisinopril—systemic scleroderma	0.000725	0.000751	CcSEcCtD
Fondaparinux sodium—Rash—Captopril—systemic scleroderma	0.000724	0.00075	CcSEcCtD
Fondaparinux sodium—Dermatitis—Captopril—systemic scleroderma	0.000724	0.000749	CcSEcCtD
Fondaparinux sodium—Somnolence—Lisinopril—systemic scleroderma	0.000723	0.000749	CcSEcCtD
Fondaparinux sodium—Headache—Captopril—systemic scleroderma	0.00072	0.000745	CcSEcCtD
Fondaparinux sodium—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000719	0.000744	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Lisinopril—systemic scleroderma	0.000716	0.000742	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000714	0.000739	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000714	0.000739	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000713	0.000738	CcSEcCtD
Fondaparinux sodium—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000713	0.000738	CcSEcCtD
Fondaparinux sodium—Infection—Mycophenolate mofetil—systemic scleroderma	0.000708	0.000733	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Lisinopril—systemic scleroderma	0.000707	0.000732	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000702	0.000727	CcSEcCtD
Fondaparinux sodium—Fatigue—Lisinopril—systemic scleroderma	0.000701	0.000726	CcSEcCtD
Fondaparinux sodium—Shock—Mycophenolate mofetil—systemic scleroderma	0.000701	0.000726	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000699	0.000724	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000698	0.000723	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Leflunomide—systemic scleroderma	0.000698	0.000722	CcSEcCtD
Fondaparinux sodium—Constipation—Lisinopril—systemic scleroderma	0.000696	0.00072	CcSEcCtD
Fondaparinux sodium—Pain—Lisinopril—systemic scleroderma	0.000696	0.00072	CcSEcCtD
Fondaparinux sodium—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000696	0.00072	CcSEcCtD
Fondaparinux sodium—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000692	0.000717	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000689	0.000714	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Azathioprine—systemic scleroderma	0.000686	0.00071	CcSEcCtD
Fondaparinux sodium—Haemoglobin—Prednisone—systemic scleroderma	0.000684	0.000708	CcSEcCtD
Fondaparinux sodium—Nausea—Captopril—systemic scleroderma	0.000682	0.000707	CcSEcCtD
Fondaparinux sodium—Haemorrhage—Prednisone—systemic scleroderma	0.00068	0.000704	CcSEcCtD
Fondaparinux sodium—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000679	0.000704	CcSEcCtD
Fondaparinux sodium—Asthenia—Leflunomide—systemic scleroderma	0.000679	0.000703	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Lisinopril—systemic scleroderma	0.00067	0.000694	CcSEcCtD
Fondaparinux sodium—Pruritus—Leflunomide—systemic scleroderma	0.00067	0.000694	CcSEcCtD
Fondaparinux sodium—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000666	0.00069	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000665	0.000689	CcSEcCtD
Fondaparinux sodium—Dizziness—Azathioprine—systemic scleroderma	0.000663	0.000687	CcSEcCtD
Fondaparinux sodium—Asthenia—Mycophenolic acid—systemic scleroderma	0.000648	0.000671	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Leflunomide—systemic scleroderma	0.000648	0.000671	CcSEcCtD
Fondaparinux sodium—Urticaria—Lisinopril—systemic scleroderma	0.000646	0.000669	CcSEcCtD
Fondaparinux sodium—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000645	0.000668	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Lisinopril—systemic scleroderma	0.000643	0.000666	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Lisinopril—systemic scleroderma	0.000643	0.000666	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.00064	0.000663	CcSEcCtD
Fondaparinux sodium—Pruritus—Mycophenolic acid—systemic scleroderma	0.000639	0.000662	CcSEcCtD
Fondaparinux sodium—Vomiting—Azathioprine—systemic scleroderma	0.000637	0.00066	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000635	0.000658	CcSEcCtD
Fondaparinux sodium—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000634	0.000656	CcSEcCtD
Fondaparinux sodium—Infestation NOS—Methotrexate—systemic scleroderma	0.000633	0.000656	CcSEcCtD
Fondaparinux sodium—Infestation—Methotrexate—systemic scleroderma	0.000633	0.000656	CcSEcCtD
Fondaparinux sodium—Rash—Azathioprine—systemic scleroderma	0.000632	0.000655	CcSEcCtD
Fondaparinux sodium—Dermatitis—Azathioprine—systemic scleroderma	0.000632	0.000654	CcSEcCtD
Fondaparinux sodium—Flushing—Prednisone—systemic scleroderma	0.000631	0.000654	CcSEcCtD
Fondaparinux sodium—Headache—Azathioprine—systemic scleroderma	0.000628	0.00065	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000627	0.00065	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—SELP—systemic scleroderma	0.000627	0.0183	CbGpPWpGaD
Fondaparinux sodium—Dizziness—Leflunomide—systemic scleroderma	0.000626	0.000648	CcSEcCtD
Fondaparinux sodium—Renal failure—Methotrexate—systemic scleroderma	0.000622	0.000645	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.00062	0.000642	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000618	0.00064	CcSEcCtD
Fondaparinux sodium—Angiopathy—Prednisone—systemic scleroderma	0.000617	0.000639	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000615	0.000637	CcSEcCtD
Fondaparinux sodium—Immune system disorder—Prednisone—systemic scleroderma	0.000614	0.000636	CcSEcCtD
Fondaparinux sodium—Pain—Mycophenolate mofetil—systemic scleroderma	0.00061	0.000631	CcSEcCtD
Fondaparinux sodium—Constipation—Mycophenolate mofetil—systemic scleroderma	0.00061	0.000631	CcSEcCtD
Fondaparinux sodium—Arrhythmia—Prednisone—systemic scleroderma	0.000608	0.000629	CcSEcCtD
Fondaparinux sodium—Haematuria—Methotrexate—systemic scleroderma	0.000604	0.000625	CcSEcCtD
Fondaparinux sodium—Vomiting—Leflunomide—systemic scleroderma	0.000602	0.000623	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Lisinopril—systemic scleroderma	0.000599	0.000621	CcSEcCtD
Fondaparinux sodium—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000599	0.00062	CcSEcCtD
Fondaparinux sodium—Dizziness—Mycophenolic acid—systemic scleroderma	0.000597	0.000619	CcSEcCtD
Fondaparinux sodium—Epistaxis—Methotrexate—systemic scleroderma	0.000597	0.000618	CcSEcCtD
Fondaparinux sodium—Rash—Leflunomide—systemic scleroderma	0.000597	0.000618	CcSEcCtD
Fondaparinux sodium—Dermatitis—Leflunomide—systemic scleroderma	0.000596	0.000618	CcSEcCtD
Fondaparinux sodium—Nausea—Azathioprine—systemic scleroderma	0.000596	0.000617	CcSEcCtD
Fondaparinux sodium—Headache—Leflunomide—systemic scleroderma	0.000593	0.000614	CcSEcCtD
Fondaparinux sodium—Malnutrition—Prednisone—systemic scleroderma	0.000592	0.000613	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000587	0.000608	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—RHOB—systemic scleroderma	0.000586	0.017	CbGpPWpGaD
Fondaparinux sodium—Asthenia—Lisinopril—systemic scleroderma	0.000584	0.000604	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000583	0.000604	CcSEcCtD
Fondaparinux sodium—Pruritus—Lisinopril—systemic scleroderma	0.000576	0.000596	CcSEcCtD
Fondaparinux sodium—Vomiting—Mycophenolic acid—systemic scleroderma	0.000574	0.000595	CcSEcCtD
Fondaparinux sodium—Haemoglobin—Methotrexate—systemic scleroderma	0.000571	0.000592	CcSEcCtD
Fondaparinux sodium—Rash—Mycophenolic acid—systemic scleroderma	0.000569	0.00059	CcSEcCtD
Fondaparinux sodium—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000569	0.000589	CcSEcCtD
Fondaparinux sodium—Haemorrhage—Methotrexate—systemic scleroderma	0.000568	0.000589	CcSEcCtD
Fondaparinux sodium—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000566	0.000586	CcSEcCtD
Fondaparinux sodium—Headache—Mycophenolic acid—systemic scleroderma	0.000566	0.000586	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000563	0.000584	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000563	0.000584	CcSEcCtD
Fondaparinux sodium—Nausea—Leflunomide—systemic scleroderma	0.000562	0.000582	CcSEcCtD
Fondaparinux sodium—Vision blurred—Prednisone—systemic scleroderma	0.000558	0.000578	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Lisinopril—systemic scleroderma	0.000557	0.000576	CcSEcCtD
Fondaparinux sodium—Anaemia—Prednisone—systemic scleroderma	0.000547	0.000567	CcSEcCtD
Fondaparinux sodium—Angioedema—Prednisone—systemic scleroderma	0.000541	0.00056	CcSEcCtD
Fondaparinux sodium—Dizziness—Lisinopril—systemic scleroderma	0.000538	0.000557	CcSEcCtD
Fondaparinux sodium—Nausea—Mycophenolic acid—systemic scleroderma	0.000537	0.000556	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—CSK—systemic scleroderma	0.000533	0.0155	CbGpPWpGaD
Fondaparinux sodium—Vertigo—Prednisone—systemic scleroderma	0.000532	0.000551	CcSEcCtD
Fondaparinux sodium—Syncope—Prednisone—systemic scleroderma	0.000531	0.00055	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000525	0.000544	CcSEcCtD
Fondaparinux sodium—Loss of consciousness—Prednisone—systemic scleroderma	0.00052	0.000539	CcSEcCtD
Fondaparinux sodium—Vomiting—Lisinopril—systemic scleroderma	0.000517	0.000536	CcSEcCtD
Fondaparinux sodium—Angiopathy—Methotrexate—systemic scleroderma	0.000516	0.000534	CcSEcCtD
Fondaparinux sodium—Immune system disorder—Methotrexate—systemic scleroderma	0.000513	0.000532	CcSEcCtD
Fondaparinux sodium—Rash—Lisinopril—systemic scleroderma	0.000513	0.000531	CcSEcCtD
Fondaparinux sodium—Convulsion—Prednisone—systemic scleroderma	0.000513	0.000531	CcSEcCtD
Fondaparinux sodium—Dermatitis—Lisinopril—systemic scleroderma	0.000512	0.000531	CcSEcCtD
Fondaparinux sodium—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000512	0.00053	CcSEcCtD
Fondaparinux sodium—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000511	0.00053	CcSEcCtD
Fondaparinux sodium—Headache—Lisinopril—systemic scleroderma	0.00051	0.000528	CcSEcCtD
Fondaparinux sodium—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000504	0.000522	CcSEcCtD
Fondaparinux sodium—Anxiety—Prednisone—systemic scleroderma	0.000502	0.00052	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—ITGAM—systemic scleroderma	0.000502	0.0146	CbGpPWpGaD
Fondaparinux sodium—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000501	0.000518	CcSEcCtD
Fondaparinux sodium—Malnutrition—Methotrexate—systemic scleroderma	0.000495	0.000512	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000488	0.000505	CcSEcCtD
Fondaparinux sodium—Dysgeusia—Methotrexate—systemic scleroderma	0.000485	0.000502	CcSEcCtD
Fondaparinux sodium—Nausea—Lisinopril—systemic scleroderma	0.000483	0.0005	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Prednisone—systemic scleroderma	0.000483	0.0005	CcSEcCtD
Fondaparinux sodium—Oedema—Prednisone—systemic scleroderma	0.000483	0.0005	CcSEcCtD
Fondaparinux sodium—Infection—Prednisone—systemic scleroderma	0.00048	0.000497	CcSEcCtD
Fondaparinux sodium—Back pain—Methotrexate—systemic scleroderma	0.000479	0.000496	CcSEcCtD
Fondaparinux sodium—Shock—Prednisone—systemic scleroderma	0.000475	0.000492	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Prednisone—systemic scleroderma	0.000474	0.000491	CcSEcCtD
Fondaparinux sodium—Tachycardia—Prednisone—systemic scleroderma	0.000472	0.000488	CcSEcCtD
Fondaparinux sodium—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000471	0.000488	CcSEcCtD
Fondaparinux sodium—Skin disorder—Prednisone—systemic scleroderma	0.000469	0.000486	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Prednisone—systemic scleroderma	0.000467	0.000484	CcSEcCtD
Fondaparinux sodium—Vision blurred—Methotrexate—systemic scleroderma	0.000466	0.000483	CcSEcCtD
Fondaparinux sodium—Anorexia—Prednisone—systemic scleroderma	0.000461	0.000477	CcSEcCtD
Fondaparinux sodium—Anaemia—Methotrexate—systemic scleroderma	0.000457	0.000474	CcSEcCtD
Fondaparinux sodium—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000453	0.000469	CcSEcCtD
Fondaparinux sodium—Rash—Mycophenolate mofetil—systemic scleroderma	0.000449	0.000465	CcSEcCtD
Fondaparinux sodium—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000449	0.000465	CcSEcCtD
Fondaparinux sodium—Headache—Mycophenolate mofetil—systemic scleroderma	0.000447	0.000462	CcSEcCtD
Fondaparinux sodium—SERPINC1—Hemostasis—MMP1—systemic scleroderma	0.000445	0.0129	CbGpPWpGaD
Fondaparinux sodium—Vertigo—Methotrexate—systemic scleroderma	0.000445	0.00046	CcSEcCtD
Fondaparinux sodium—Insomnia—Prednisone—systemic scleroderma	0.000437	0.000453	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Prednisone—systemic scleroderma	0.000434	0.000449	CcSEcCtD
Fondaparinux sodium—Cough—Methotrexate—systemic scleroderma	0.000432	0.000447	CcSEcCtD
Fondaparinux sodium—Convulsion—Methotrexate—systemic scleroderma	0.000429	0.000444	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Prednisone—systemic scleroderma	0.000425	0.00044	CcSEcCtD
Fondaparinux sodium—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000423	0.000438	CcSEcCtD
Fondaparinux sodium—Chest pain—Methotrexate—systemic scleroderma	0.000421	0.000436	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Prednisone—systemic scleroderma	0.00042	0.000435	CcSEcCtD
Fondaparinux sodium—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000418	0.000433	CcSEcCtD
Fondaparinux sodium—Fatigue—Prednisone—systemic scleroderma	0.000417	0.000431	CcSEcCtD
Fondaparinux sodium—Constipation—Prednisone—systemic scleroderma	0.000413	0.000428	CcSEcCtD
Fondaparinux sodium—Confusional state—Methotrexate—systemic scleroderma	0.000407	0.000422	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000404	0.000418	CcSEcCtD
Fondaparinux sodium—Infection—Methotrexate—systemic scleroderma	0.000401	0.000415	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Prednisone—systemic scleroderma	0.000398	0.000412	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Methotrexate—systemic scleroderma	0.000396	0.00041	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000395	0.000409	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000395	0.000409	CcSEcCtD
Fondaparinux sodium—Skin disorder—Methotrexate—systemic scleroderma	0.000392	0.000406	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Methotrexate—systemic scleroderma	0.00039	0.000404	CcSEcCtD
Fondaparinux sodium—Anorexia—Methotrexate—systemic scleroderma	0.000385	0.000399	CcSEcCtD
Fondaparinux sodium—Urticaria—Prednisone—systemic scleroderma	0.000384	0.000398	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Prednisone—systemic scleroderma	0.000382	0.000396	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Prednisone—systemic scleroderma	0.000382	0.000396	CcSEcCtD
Fondaparinux sodium—Hypotension—Methotrexate—systemic scleroderma	0.000377	0.000391	CcSEcCtD
Fondaparinux sodium—Insomnia—Methotrexate—systemic scleroderma	0.000365	0.000378	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Methotrexate—systemic scleroderma	0.000363	0.000376	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Methotrexate—systemic scleroderma	0.00036	0.000373	CcSEcCtD
Fondaparinux sodium—Somnolence—Methotrexate—systemic scleroderma	0.000359	0.000372	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Prednisone—systemic scleroderma	0.000356	0.000369	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Methotrexate—systemic scleroderma	0.000355	0.000368	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Methotrexate—systemic scleroderma	0.000351	0.000364	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000349	0.000361	CcSEcCtD
Fondaparinux sodium—Fatigue—Methotrexate—systemic scleroderma	0.000348	0.000361	CcSEcCtD
Fondaparinux sodium—Asthenia—Prednisone—systemic scleroderma	0.000347	0.000359	CcSEcCtD
Fondaparinux sodium—Pain—Methotrexate—systemic scleroderma	0.000345	0.000358	CcSEcCtD
Fondaparinux sodium—Pruritus—Prednisone—systemic scleroderma	0.000342	0.000354	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Methotrexate—systemic scleroderma	0.000333	0.000345	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Prednisone—systemic scleroderma	0.000331	0.000342	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.00033	0.000342	CcSEcCtD
Fondaparinux sodium—SERPINC1—Hemostasis—NOS3—systemic scleroderma	0.000322	0.00938	CbGpPWpGaD
Fondaparinux sodium—Urticaria—Methotrexate—systemic scleroderma	0.000321	0.000332	CcSEcCtD
Fondaparinux sodium—Dizziness—Prednisone—systemic scleroderma	0.00032	0.000331	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Methotrexate—systemic scleroderma	0.000319	0.000331	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Methotrexate—systemic scleroderma	0.000319	0.000331	CcSEcCtD
Fondaparinux sodium—F10—Metabolism of proteins—ACE—systemic scleroderma	0.000308	0.00896	CbGpPWpGaD
Fondaparinux sodium—Vomiting—Prednisone—systemic scleroderma	0.000307	0.000318	CcSEcCtD
Fondaparinux sodium—Rash—Prednisone—systemic scleroderma	0.000305	0.000315	CcSEcCtD
Fondaparinux sodium—Dermatitis—Prednisone—systemic scleroderma	0.000304	0.000315	CcSEcCtD
Fondaparinux sodium—Headache—Prednisone—systemic scleroderma	0.000303	0.000313	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Methotrexate—systemic scleroderma	0.000298	0.000308	CcSEcCtD
Fondaparinux sodium—Asthenia—Methotrexate—systemic scleroderma	0.00029	0.0003	CcSEcCtD
Fondaparinux sodium—Nausea—Prednisone—systemic scleroderma	0.000287	0.000297	CcSEcCtD
Fondaparinux sodium—Pruritus—Methotrexate—systemic scleroderma	0.000286	0.000296	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Methotrexate—systemic scleroderma	0.000276	0.000286	CcSEcCtD
Fondaparinux sodium—Dizziness—Methotrexate—systemic scleroderma	0.000267	0.000277	CcSEcCtD
Fondaparinux sodium—Vomiting—Methotrexate—systemic scleroderma	0.000257	0.000266	CcSEcCtD
Fondaparinux sodium—Rash—Methotrexate—systemic scleroderma	0.000255	0.000264	CcSEcCtD
Fondaparinux sodium—Dermatitis—Methotrexate—systemic scleroderma	0.000254	0.000263	CcSEcCtD
Fondaparinux sodium—Headache—Methotrexate—systemic scleroderma	0.000253	0.000262	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—MMP1—systemic scleroderma	0.000251	0.00731	CbGpPWpGaD
Fondaparinux sodium—Nausea—Methotrexate—systemic scleroderma	0.00024	0.000248	CcSEcCtD
Fondaparinux sodium—SERPINC1—Hemostasis—TGFB1—systemic scleroderma	0.000213	0.0062	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—MMP1—systemic scleroderma	0.000198	0.00575	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—NOS3—systemic scleroderma	0.000182	0.0053	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—CCL2—systemic scleroderma	0.000161	0.00468	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—MMP2—systemic scleroderma	0.000153	0.00445	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—TGFB1—systemic scleroderma	0.00012	0.00351	CbGpPWpGaD
